Linezolid Zentiva

Linezolid, the active ingredient in Linezolid Zentiva, is a oxazolidinone antibiotic presented as an oral dosage form for oral use. It treats infections caused by susceptible Gram‑positive bacteria, including methicillin‑resistant Staphylococcus aureus (MRSA) and vancomycin‑resistant Enterococcus (VRE), in adult patients.

GNH USA supplies Linezolid Zentiva as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Linezolid is used to treat infections caused by Gram‑positive bacteria, particularly those resistant to other agents. It is effective in several clinical scenarios: - Complicated skin and soft‑tissue infections: eradicates susceptible MRSA and other Gram‑positive pathogens. - Hospital‑acquired pneumonia, including ventilator‑associated pneumonia: provides coverage against resistant Gram‑positive organisms. - Bloodstream infections (bacteremia) caused by MRSA or VRE: achieves bacterial clearance in systemic infections. - Community‑acquired bacterial pneumonia (when caused by susceptible strains): offers an oral treatment option.

Linezolid may cause a range of adverse reactions, ranging from mild to serious.

Common Side Effects: - Nausea: mild to moderate gastrointestinal upset. - Diarrhea: loose stools, occasionally watery. - Headache: transient cranial discomfort. - Vomiting: occasional emesis. - Metallic taste: altered taste perception. - Myelosuppression: mild reductions in blood cell counts.

Serious or Rare Side Effects: - Thrombocytopenia: significant drop in platelet count. - Anemia: reduced red blood cell levels. - Peripheral neuropathy: tingling or numbness in extremities. - Optic neuropathy: visual disturbances, potentially irreversible. - Lactic acidosis: metabolic acidosis with elevated lactate. - Serotonin syndrome: risk when combined with serotonergic agents.

When prescribing Linezolid, clinicians should consider several safety measures: - Renal impairment: monitor renal function and adjust therapy as needed. - Hepatic impairment: assess liver enzymes regularly. - Concomitant serotonergic drugs: avoid due to risk of serotonin syndrome. - Myelosuppression: perform periodic complete blood counts. - Pregnancy and lactation: use only if benefits outweigh potential risks. - Store at ambient temperature: keep in the original packaging, protect from moisture and direct sunlight.

Linezolid interacts with several drug classes, requiring careful management.

Major Interactions (Avoid): - Serotonergic agents (e.g., SSRIs, SNRIs, MAO inhibitors): may precipitate serotonin syndrome. - Rifampin: induces metabolism, reducing linezolid plasma concentrations. - Monoamine oxidase inhibitors: increase risk of hypertensive crisis.

Moderate Interactions (Monitor Closely): - Warfarin: may enhance anticoagulant effect, monitor INR. - Phenytoin: may lower linezolid levels, consider therapeutic monitoring. - Oral contraceptives: efficacy may be reduced, advise alternative contraception.